Analyst firms · Robert W. Baird · HSIC

Robert W. Baird HSIC price target and rating history

Henry Schein Inc. (HSIC) · Health Care

Robert W. Baird rates Henry Schein Inc. (HSIC) Outperform with a $100 price target, as of its latest action on Feb 23, 2026. It has published 4 rating actions on HSIC since June 2022, including 2 upgrades and 2 downgrades. Across 5 firms with a HSIC price target in the last 12 months, the median target is $100. Robert W. Baird's target matches it.

Current rating
Outperform
Price target
$100
Median target, all firms
$100
Actions on HSIC
4

Robert W. Baird price target on HSIC

$100$86$722023202420252026
Robert W. Baird price target on HSIC, each point a stated target, June 2022 to February 2026.

Every Robert W. Baird rating on HSIC

How other firms rate HSIC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BMO Capital MarketsMarket Perform$85Jul 9, 2026
BTIGBuy$100Jun 11, 2026
CitigroupBuy$100Apr 15, 2026
Robert W. BairdOutperform$100Feb 23, 2026
BarclaysOverweight$86Dec 9, 2025

Questions about Robert W. Baird and HSIC

What is Robert W. Baird's price target for HSIC?
Robert W. Baird's latest stated price target for Henry Schein Inc. (HSIC) is $100, from its action on Feb 23, 2026.
What is Robert W. Baird's rating on HSIC?
Robert W. Baird rates HSIC Outperform, a bullish rating, as of Feb 23, 2026.
When did Robert W. Baird last change its view on HSIC?
On Feb 23, 2026, Robert W. Baird upgrades to Outperform from Neutral, price target $100.
How does Robert W. Baird's HSIC target compare with other analysts?
Across 5 firms with a HSIC price target in the last 12 months, the median target is $100. Robert W. Baird's target matches it.

More HSIC rating histories

All Robert W. Baird ratingsHSIC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.